Depression: A major, unrecognized risk factor for osteoporosis?

Trends in Endocrinology and Metabolism

Volumn 12, Issue 5, 2001, Pages 198-203

  Cizza, Giovanni ^a   Ravn, Pernille ^b   Chrousos, George P ^c   Gold, Philip W ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b CENTER FOR CLINICAL AND BASIC RESEARCH   (Denmark)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; PSYCHOTROPIC AGENT;

BONE DENSITY; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DEPRESSION; FRACTURE; HUMAN; METABOLISM; OSTEOPOROSIS; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR;

ANTIDEPRESSIVE AGENTS; BONE DENSITY; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DEPRESSION; FRACTURES, BONE; HUMANS; OSTEOPOROSIS; PSYCHOTROPIC DRUGS; RISK FACTORS;

EID: 0035403020     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(01)00407-6     Document Type: Review

References (48)

1. Robins, L.N. et al. (1984) Lifetime prevalence of specific psychiatry disorders in three sites. Arch. Gen. Psychiatry 41, 949-958
2. Zheng, D. et al. (1997) Major depression and all-cause mortality among white adults in the United States. Ann. Epidemiol. 7, 213-218
3. Steckler, T. et al. (1999) Glucocorticoids and depression. Bailliere's Best Pract. Res. Clin. Endocrinol. Metab. 4, 597-614
4. Rosmond, R. and Bjorntorp, P. (1998) Endocrine and metabolic aberrations in men with abdominal obesity in relation to anxio-depressive infirmity. Metabolism 10, 187-193
5. Chrousos, G.P. and Gold, P.W. (1998) A healthy body in a healthy mind - and vice versa - the damaging power of 'uncontrollable' stress. J. Clin. Endocrinol. Metab. 83, 1842-1845
6. Genco, R.J. et al. (1999) Relationship of stress, distress and inadequate coping behaviors to periodontal disease. J. Periodontol. 70, 711-723
7. Bjorntorp, P. and Rosmond, R. (2000) The metabolic syndrome - a neuroendocrine disorder? Br. J. Nutr. 83, S49-S57
8. Chrousos, G.P and Gold, P.W. (1992) The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. J. Am. Med. Assoc. 267, 1244-1252
9. Consensus Development Conference Diagnosis (1993) Prophylaxis and treatment of osteoporosis. Am. J. Med. 94, 636-638
10. Marwick, C. (2000) Consensus panel considers osteoporosis. J. Am. Med. Assoc. 283, 2093-2095
11. Michelson, D. et al. (1996) Bone mineral density in women with depression. New Engl. J. Med. 335, 1176-1181
12. Schweiger, U. et al. (1994) Low lumbar bone mineral density in patients with major depression. Am. J. Psychiatry 151, 1691-1693
13. Schweiger, U. et al. (2000) Lumbar bone mineral density in patients with major depression: evidence of increased bone loss at follow-up. Am. J. Psychiatry 157, 118-120
14. Ross, P.D. et al. (1990) A critical review of bone mass and the risk of fractures in osteoporosis. Calcif. Tissue Int. 46, 149-161
15. Hay, P. (1996) Treatable risk factor for osteoporosis? Am. J. Psychiatry 153, 140
16. Whooley M.A. et al. (1999) Depression, falls and risk of fracture in older women. Study of osteoporotic fractures research group. Arch. Intern. Med 159, 484-490
17. Ravn, P et al. (1999) Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. Early Postmenopausal Intervention Cohort (EPIC) Study Group. J. Bone Miner. Res. 14, 1622-1627
18. Drinka, P.J. et al. (1992) The effect of overlying calcifications on lumbar bone densitometry. Calcif. Tissuelnt. 50, 507-510
19. Ryan, P.J. et al. (1992) The effect of vertebral collapse on spinal bone mineral density measurements in osteoporosis. Bone Miner. 18, 267-272
20. Halbreich, U. et al. (1995) Decreased bone mineral density in medicated psychiatric patients. Psychosom. Med. 57, 485-491
21. Coelho, R. et al. (1999) Bone mineral density and depression: a community study in women. J. Psychosom. Res. 46, 29-35
22. Melton, J.A., III et al. (1992) Perspective: How many women have osteoporosis? J. Bone Miner. Res. 7, 1005-1010
23. Reginster, J.Y. (1999) Depressive vulnerability is not an independent risk factor for osteoporosis in postmenopausal women. Maturitas 33, 133-137
24. Leipzig, R.M. et al. (1999) Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J. Am. Geriatr. Soc. 47, 30-39
25. Liu, B. et al. (1998) Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people. Lancet 351, 1303-1307
26. Granek, E. et al. (1987) Medications and diagnoses in relation to falls in a long-term care facility. J. Am. Geriatr. Soc. 35, 503-511
27. Brown, E.M. (1981) Lithium induces abnormal calcium-regulated PTH release in dispersed bovine parathyroid cells. J. Clin. Endocrinol. Metab. 52, 1046-1048
28. Bendz, H. et al. (1996) Hyperparathyroidism and long-term lithium therapy - a cross-sectional study and the effect of lithium withdrawal. J. Intern. Med 240, 357-365
29. Mak, T.W. et al. (1998) Effects of lithium therapy on bone mineral metabolism: a two-year prospective longitudinal study. J. Clin. Endocrinol. Metab. 83, 3857-3859
30. Cohen, O. et al. (1998) Lithium carbonate therapy is not a risk factor for osteoporosis. Horm. Metab. Res. 30, 594-597
31. Greenspan, S.L. and Greenspan, F.S. (1999) The effect of thyroid hormone on skeletal integrity. Ann. Intern. Med. 130, 750-758
32. Gyulai, L. et al. (1997) Bone mineral density and L-thyroxine treatment in rapidly cycling bipolar disorder. Biol. Psychiatry 41, 503-506
33. Ziegler, R. and Kasperk, C. (1998) Glucocorticoid-induced osteoporosis: prevention and treatment. Steroids 63, 344-348
34. Hermus, A.R. et al. (1995) Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome. J. Clin. Endocrinol. Metab. 80, 2859-2865
35. Cizza, G. et al. (1996) Factitious Cushing syndrome. J. Clin. Endocrinol. Metab. 81, 3573-3577
36. Harper, K.D. and Weber, T.J. (1998) Secondary osteoporosis. Diagnostic considerations. Endocrinol. Metab. Clin. North Am. 27, 325-348
37. Papanicolaou, D.A. et al. (1998) The pathophysiologic roles of interleukin-6 in human disease. Ann. Intern. Med. 128, 127-137
38. Licinio, J. and Wong, M.L. (1999) The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. Mol. Psychiatry 4, 317-327
39. Dentino, A.N. et al. (1999) Association of interleukin-6 and other biological variables with depression in older people living in the community. J. Am. Geriatr. Soc. 47, 6-11
40. Wong, M.L. et al. (1999) Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone Proc. Natl. Acad. Sci. U. S. A. 97, 325-330
41. Ducy P. et al. (1999) Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100, 197-207
42. Antonijevic, I.A. et al. (1998) Elevated nocturnal profiles of serum leptin in patients with depression. J. Psychiatr. Res. 32, 403-410
43. Horrobin, D.F. and Bennett, C.N. (1999) Depression and bipolar disorder: relationships to impaired fatty acid and phospholipids metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer ageing, and osteoporosis. Possible candidate genes. Prostaglandins Leukot. Essent. Fatty Acids 60, 217-234
44. Salkeld, G. et al. (2000) Quality of life related to fear of falling and hip fracture in older women: a time trade off study. Br. Med. J. 320, 241-246
45. Lindsay R. and Meunier, P. (1998) Osteoporosis: review of the evidence for prevention, diagnosis and treatment and cost-effectiveness analysis. Osteoporos. Int. 8, 11-21
46. Thornton, A. and Lee, P (2000) Publication bias in meta-analysis: its causes and consequences. J. Clin. Epidemiol. 53, 207-216
47. Orwoll, E. et al. (2000) Alendronate for the treatment of osteoporosis in men. New Engl. J. Med. 343, 604-610
48. Ebeling, P.R. (1998) Osteoporosis in men. New insights into aetiology, pathogenesis, prevention and management. Drugs Aging 13, 421-434